NASDAQ_GWPH_2013

Loading viewer...

annual_report

Format: PDF annual_report

GW Pharmaceuticals' 2013 Annual Report highlights significant advancements in cannabinoid medicines, including Sativex and Epidiolex, and IPO success.

Browse all annual_reports →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from GW Pharmaceuticals

View all →

presentation

GW Pharmaceuticals GWPH 2017 Corporate Presentation

investor_presentation

40 Pages

Similar annual_reports from other companies

Browse all →

Antero Midstream 2022 Annual Report 10-K

annual_report

102 Pages

Antero Midstream

annual_report

Bilfinger SE